Moderna’s COVID-19 Vaccine Supply Agreement with Israel

Gornitzky represented Moderna in the deal.

Israel has signed an agreement with Moderna Inc for the future purchase of its potential COVID-19 vaccine.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

The Gornitzky team advising Moderna was led by Partners Pinchas Rubin (Picture), Chaim Friedland, Jonathan Raff and Assaf Harel, together with associate Carolyn Zeimer and Giogdani, Dr. Jonathan Shiman and Josh Cohen.

Involved fees earner: Josh Cohn – Gornitzky & Co.; Chaim Friedland – Gornitzky & Co.; Assaf Harel – Gornitzky & Co.; Yehonatan Raff – Gornitzky & Co.; Pinhas Rubin – Gornitzky & Co.; Yehonatan Shiman – Gornitzky & Co.; Carolyn Zeimer Vigodny – Gornitzky & Co.;

Law Firms: Gornitzky & Co.;

Clients: Moderna Inc.;


Author: Michael Patrini.